関連レポート

ピロリ菌非侵襲的検査の世界市場：2031年予測

出版元：Transparency Market Research  出版元について

発行年：2024年4月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 210ページになります。

商品コード：TMR253

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

微生物検査技術の世界市場規模は2023年で42億ドル、2034年末までに104億ドル、2024年から2034年にかけての市場の平均年成長率は8.6%で推移することが見込まれています。

当レポートでは、微生物検査技術の市場予測-2034年、各種セグメント別市場分析(適応疾患別、技術別、国地域別、等)、市場ダイナミクス、パイプライン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■微生物検査技術の世界市場予測2020-2034年
・市場規模(US$)

■適応疾患別、市場-2034年
・呼吸器疾患
・神経疾患
・感染症
・その他
※(市場規模US$)

■技術別、市場-2034年
・細胞培養
・顕微鏡検査
・血清学
※(市場規模US$)

■用途別、市場-2034年
・診断
・治療モニタリング
※(市場規模US$)

■エンドユーザー別、市場-2034年
・病院検査室
・病理検査室
・研究機関
・その他
※(市場規模US$)

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
・市場ダイナミクス（促進要因、障壁、機会）
・パイプライン分析
・主要製品/ブランド分析
・競合状況

■微生物検査技術の主要企業プロフィール動向
・Abbott Laboratories
・Agilent Technologies
・Beckman Coulter, Inc. (a Danaher Segment)
・Becton, Dickinson and Company
・Bio-Rad Laboratories, Inc.
・bioMérieux
・F. Hoffmann-La Roche Ltd.
・HiMedia Laboratories Private Limited
・Hologic Inc.
・Thermo Fisher Scientific

（全210頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Microbiology Testing Technologies Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Indication
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Indication, 2020-2034
6.3.1. Respiratory Diseases
6.3.2. Neurological Diseases
6.3.3. Infectious Diseases
6.3.4. Others
6.4. Market Attractiveness, by Indication

7. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. Cell Culture
7.3.2. Microscopy
7.3.3. Serology
7.4. Market Attractiveness, by Technology

8. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Diagnostic
8.3.2. Treatment Monitoring
8.4. Market Attractiveness, by Application

9. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospital Labs
9.3.2. Pathology Labs
9.3.3. Research Institutes
9.3.4. Others
9.4. Market Attractiveness, by End-user

10. Global Medical Microbiology Testing Technologies Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region

11. North America Medical Microbiology Testing Technologies Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Indication, 2020-2034
11.2.1. Respiratory Diseases
11.2.2. Neurological Diseases
11.2.3. Infectious Diseases
11.2.4. Others
11.3. Market Attractiveness, by Indication
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. Cell Culture
11.4.2. Microscopy
11.4.3. Serology
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Diagnostic
11.6.2. Treatment Monitoring
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospital Labs
11.8.2. Pathology Labs
11.8.3. Research Institutes
11.8.4. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Indication
11.11.2. By Technology
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country

12. Europe Medical Microbiology Testing Technologies Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Indication, 2020-2034
12.2.1. Respiratory Diseases
12.2.2. Neurological Diseases
12.2.3. Infectious Diseases
12.2.4. Others
12.3. Market Attractiveness, by Indication
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. Cell Culture
12.4.2. Microscopy
12.4.3. Serology
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Diagnostic
12.6.2. Treatment Monitoring
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospital Labs
12.8.2. Pathology Labs
12.8.3. Research Institutes
12.8.4. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Indication
12.11.2. By Technology
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region

13. Asia Pacific Medical Microbiology Testing Technologies Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Indication, 2020-2034
13.2.1. Respiratory Diseases
13.2.2. Neurological Diseases
13.2.3. Infectious Diseases
13.2.4. Others
13.3. Market Attractiveness, by Indication
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. Cell Culture
13.4.2. Microscopy
13.4.3. Serology
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Diagnostic
13.6.2. Treatment Monitoring
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospital Labs
13.8.2. Pathology Labs
13.8.3. Research Institutes
13.8.4. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Indication
13.11.2. By Technology
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region

14. Latin America Medical Microbiology Testing Technologies Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Indication, 2020-2034
14.2.1. Respiratory Diseases
14.2.2. Neurological Diseases
14.2.3. Infectious Diseases
14.2.4. Others
14.3. Market Attractiveness, by Indication
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. Cell Culture
14.4.2. Microscopy
14.4.3. Serology
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Diagnostic
14.6.2. Treatment Monitoring
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospital Labs
14.8.2. Pathology Labs
14.8.3. Research Institutes
14.8.4. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Indication
14.11.2. By Technology
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region

15. Middle East & Africa Medical Microbiology Testing Technologies Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Indication, 2020-2034
15.2.1. Respiratory Diseases
15.2.2. Neurological Diseases
15.2.3. Infectious Diseases
15.2.4. Others
15.3. Market Attractiveness, by Indication
15.4. Market Value Forecast, by Technology, 2020-2034
15.4.1. Cell Culture
15.4.2. Microscopy
15.4.3. Serology
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Diagnostic
15.6.2. Treatment Monitoring
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospital Labs
15.8.2. Pathology Labs
15.8.3. Research Institutes
15.8.4. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Indication
15.11.2. By Technology
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Agilent Technologies
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Beckman Coulter, Inc. (a Danaher segment)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Becton, Dickinson and Company
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Bio-Rad Laboratories, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. bioMérieux
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. F. Hoffmann-La Roche Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. HiMedia Laboratories Private Limited
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Hologic Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Thermo Fisher Scientific
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview

List of Tables

Table 01: Global Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 02: Global Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 03: Global Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 05: Global Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 06: North America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 07: North America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 08: North America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 09: North America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 10: North America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 11: Europe Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 12: Europe Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 13: Europe Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 14: Europe Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 15: Europe Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 16: Asia Pacific Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Asia Pacific Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 18: Asia Pacific Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 19: Asia Pacific Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 20: Asia Pacific Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Latin America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Latin America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 23: Latin America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 24: Latin America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 25: Latin America Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 26: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 27: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Indication, 2020-2034

Table 28: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 29: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by Application, 2020-2034

Table 30: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Medical Microbiology Testing Technologies Market Size (US$ Mn), by Region, 2023 and 2034

Figure 02: Global Medical Microbiology Testing Technologies Market Revenue (US$ Mn), by Indication, 2023

Figure 03: Global Medical Microbiology Testing Technologies Market Value Share, by Indication, 2023

Figure 04: Global Medical Microbiology Testing Technologies Market Revenue (US$ Mn), by Technology, 2023

Figure 05: Global Medical Microbiology Testing Technologies Market Value Share, by Technology, 2023

Figure 06: Global Medical Microbiology Testing Technologies Market Revenue (US$ Mn), by Application, 2023

Figure 07: Global Medical Microbiology Testing Technologies Market Value Share, by Application, 2023

Figure 08: Global Medical Microbiology Testing Technologies Market Revenue (US$ Mn), by End-user, 2023

Figure 09: Global Medical Microbiology Testing Technologies Market Value Share, by End-user, 2023

Figure 10: Global Medical Microbiology Testing Technologies Market Value Share, by Region, 2023

Figure 11: Global Medical Microbiology Testing Technologies Market Value (US$ Mn) Forecast, 2020-2034

Figure 12: Global Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 13: Global Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 14: Global Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 15: Global Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 16: Global Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 17: Global Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 18: Global Medical Microbiology Testing Technologies Market Revenue (US$ Mn), by End-user, 2023

Figure 19: Global Medical Microbiology Testing Technologies Market Value Share, by End-user, 2023

Figure 20: Global Medical Microbiology Testing Technologies Market Value Share Analysis, by Region, 2023 and 2034

Figure 21: Global Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Region, 2024-2034

Figure 22: North America Medical Microbiology Testing Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 23: North America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Country, 2024-2034

Figure 24: North America Medical Microbiology Testing Technologies Market Value Share Analysis, by Country, 2023 and 2034

Figure 25: North America Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 26: North America Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 27: North America Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 28: North America Medical Microbiology Testing Technologies Market Value Share Analysis, by End-user, 2023 and 2034

Figure 29: North America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 30: North America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 31: North America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 32: North America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by End-user, 2024-2034

Figure 33: Europe Medical Microbiology Testing Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 34: Europe Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 35: Europe Medical Microbiology Testing Technologies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 36: Europe Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 37: Europe Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 38: Europe Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 39: Europe Medical Microbiology Testing Technologies Market Value Share Analysis, by End-user, 2023 and 2034

Figure 40: Europe Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 41: Europe Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 42: Europe Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 43: Europe Medical Microbiology Testing Technologies Market Attractiveness Analysis, by End-user, 2024-2034

Figure 44: Asia Pacific Medical Microbiology Testing Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 45: Asia Pacific Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 46: Asia Pacific Medical Microbiology Testing Technologies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 47: Asia Pacific Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 48: Asia Pacific Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 49: Asia Pacific Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 50: Asia Pacific Medical Microbiology Testing Technologies Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Asia Pacific Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 52: Asia Pacific Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 53: Asia Pacific Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 54: Asia Pacific Medical Microbiology Testing Technologies Market Attractiveness Analysis, by End-user, 2023-2034

Figure 55: Latin America Medical Microbiology Testing Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 56: Latin America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 57: Latin America Medical Microbiology Testing Technologies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 58: Latin America Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 59: Latin America Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 60: Latin America Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 61: Latin America Medical Microbiology Testing Technologies Market Value Share Analysis, by End-user, 2023 and 2034

Figure 62: Latin America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 63: Latin America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 64: Latin America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 65: Latin America Medical Microbiology Testing Technologies Market Attractiveness Analysis, by End-user, 2024-2034

Figure 66: Middle East & Africa Medical Microbiology Testing Technologies Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 67: Middle East & Africa Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 68: Middle East & Africa Medical Microbiology Testing Technologies Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 69: Middle East & Africa Medical Microbiology Testing Technologies Market Value Share Analysis, by Indication, 2023 and 2034

Figure 70: Middle East & Africa Medical Microbiology Testing Technologies Market Value Share Analysis, by Technology, 2023 and 2034

Figure 71: Middle East & Africa Medical Microbiology Testing Technologies Market Value Share Analysis, by Application, 2023 and 2034

Figure 72: Middle East & Africa Medical Microbiology Testing Technologies Market Value Share Analysis, by End-user, 2023 and 2034

Figure 73: Middle East & Africa Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Indication, 2024-2034

Figure 74: Middle East & Africa Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Technology, 2024-2034

Figure 75: Middle East & Africa Medical Microbiology Testing Technologies Market Attractiveness Analysis, by Application, 2024-2034

Figure 76: Middle East & Africa Medical Microbiology Testing Technologies Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る